Literature DB >> 24209768

Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD.

Henry Chrystyn1, Mark Small2, Gary Milligan2, Victoria Higgins2, Esther Garcia Gil3, Jordi Estruch4.   

Abstract

OBJECTIVE: To examine the relationships between inhaler satisfaction, treatment compliance and health status in patients with chronic obstructive pulmonary disease (COPD).
METHODS: In a large, multinational, cross-sectional, real-world survey, respiratory specialists and primary care physicians provided information on six consecutive patients with COPD, who were then asked to complete a questionnaire. Physician-assessed compliance was scored (5-point Likert scale) and patients rated overall satisfaction with their maintenance inhaler (7-point Likert scale). Health status assessments included frequency of exacerbations and hospitalizations due to exacerbations in the past 12 months.
RESULTS: The analysis included 1443 patients (71.8% male; mean age 65.2 years). Patients' overall satisfaction with their inhaler was significantly associated with treatment compliance (χ(2) - df = 89.7; p < 0.001). Male gender (χ(2) - df = 2.9; p < 0.05) and fewer maintenance drugs (χ(2) - df = 17.7; p < 0.001) were also associated with compliance; age and breathlessness severity were not. Attributes influencing inhaler satisfaction mainly related to durability, ergonomics and ease of use. Small but statistically significant associations were observed between increasing treatment compliance and fewer exacerbations (R(2) = 0.037; p < 0.001) and fewer hospitalizations due to exacerbations (R(2) = 0.025; p < 0.001). There was a direct association between inhaler satisfaction and fewer exacerbations (R(2) = 0.03; p < 0.001).
CONCLUSIONS: Treatment compliance appears to be modestly associated with inhaler satisfaction, better health status and less frequent COPD exacerbations, although other factors are also likely to be involved. Durability, ergonomics and ease-of-use are inhaler attributes that influence patient satisfaction.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic obstructive pulmonary disease (COPD); Compliance; Exacerbations; Inhaler devices; Satisfaction

Mesh:

Substances:

Year:  2013        PMID: 24209768     DOI: 10.1016/j.rmed.2013.09.021

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  59 in total

1.  Association of clinician burnout and perceived clinician-patient communication.

Authors:  Bernard P Chang; Eileen Carter; Nina Ng; Caitlin Flynn; Timothy Tan
Journal:  Am J Emerg Med       Date:  2017-07-08       Impact factor: 2.469

2.  In Vitro Determination of Respimat® Dose Delivery in Children: An Evaluation Based on Inhalation Flow Profiles and Mouth-Throat Models.

Authors:  Deborah Bickmann; Wolfgang Kamin; Ashish Sharma; Herbert Wachtel; Petra Moroni-Zentgraf; Stefan Zielen
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2015-06-22       Impact factor: 2.849

3.  Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair® in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial.

Authors:  Pinar Yildiz; Mesut Bayraktaroglu; Didem Gorgun; Kivanc Yuksel
Journal:  Clin Drug Investig       Date:  2019-10       Impact factor: 2.859

4.  Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS survey.

Authors:  Rocco Haase; Jennifer S Kullmann; Tjalf Ziemssen
Journal:  Ther Adv Neurol Disord       Date:  2016-03-15       Impact factor: 6.570

5.  Impact of patient satisfaction with his or her inhaler on adherence and asthma control.

Authors:  Vicente Plaza; Jordi Giner; Myriam Calle; Paula Rytilä; Carlos Campo; Paula Ribó; Antonio Valero
Journal:  Allergy Asthma Proc       Date:  2018-10-18       Impact factor: 2.587

Review 6.  Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.

Authors:  Federico Lavorini; Claudia Mannini; Elisa Chellini; Giovanni A Fontana
Journal:  Drugs Aging       Date:  2016-07       Impact factor: 3.923

7.  Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Treated with Nebulized Arformoterol Following a Respiratory Event.

Authors:  Maryam Navaie; Bartolome R Celli; Zhun Xu; Soojin Cho-Reyes; Carole Dembek; Todd P Gilmer
Journal:  Chronic Obstr Pulm Dis       Date:  2019-10-23

8.  Development of the Advancing the Patient Experience in COPD Registry: A Modified Delphi Study.

Authors:  Chelsea L Edwards; Alan G Kaplan; Barbara P Yawn; Janwillem W H Kocks; Lakmini Bulathsinhala; Victoria A Carter; Ku-Lang Chang; Chester Fox; Gokul Gopalan; MeiLan K Han; Maja Kruszyk; Chantal E Le Lievre; Cathy Mahle; Barry Make; Wilson D Pace; Chris Price; Asif Shaikh; Neil Skolnik; David B Price
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01

9.  ELLIPTA Versus DISKUS plus HandiHaler in COPD: A Randomized, Open-Label, Crossover Study in a Clinical Trial Setting.

Authors:  Edward M Kerwin; Selwyn Spangenthal; Michael Zvarich; Valerie Millar; Renu Jain; Kathryn Collison; Raj Sharma
Journal:  Chronic Obstr Pulm Dis       Date:  2020-04

10.  Evaluation of In-Hospital Management of Inhaler Therapy for Chronic Obstructive Pulmonary Disease.

Authors:  Brittany Gage; Julia Lamb; Karen Dahri
Journal:  Can J Hosp Pharm       Date:  2021-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.